Impact of caloric and dietary restriction regimens on markers of health and longevity in humans and animals: a summary of available findings by Trepanowski, John F et al.
REVIEW Open Access
Impact of caloric and dietary restriction regimens
on markers of health and longevity in humans
and animals: a summary of available findings
John F Trepanowski, Robert E Canale, Kate E Marshall, Mohammad M Kabir and Richard J Bloomer
*
Abstract
Considerable interest has been shown in the ability of caloric restriction (CR) to improve multiple parameters of
health and to extend lifespan. CR is the reduction of caloric intake - typically by 20 - 40% of ad libitum
consumption - while maintaining adequate nutrient intake. Several alternatives to CR exist. CR combined with
exercise (CE) consists of both decreased caloric intake and increased caloric expenditure. Alternate-day fasting
(ADF) consists of two interchanging days; one day, subjects may consume food ad libitum (sometimes equaling
twice the normal intake); on the other day, food is reduced or withheld altogether. Dietary restriction (DR) -
restriction of one or more components of intake (typically macronutrients) with minimal to no reduction in total
caloric intake - is another alternative to CR. Many religions incorporate one or more forms of food restriction. The
following religious fasting periods are featured in this review: 1) Islamic Ramadan; 2) the three principal fasting
periods of Greek Orthodox Christianity (Nativity, Lent, and the Assumption); and 3) the Biblical-based Daniel Fast.
This review provides a summary of the current state of knowledge related to CR and DR. A specific section is
provided that illustrates related work pertaining to religious forms of food restriction. Where available, studies
involving both humans and animals are presented. The review includes suggestions for future research pertaining
to the topics of discussion.
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Introduction
Since the seminal work of McCay et al. [1], much inter-
est has been shown in caloric restriction’s ability to
improve health and to extend lifespan. Caloric restric-
tion (CR) is the reduction of caloric intake - typically by
20 - 40% of ad libitum consumption - while maintaining
adequate nutrient intake [2]. In species as diverse as
fruit flies [3], guppies [4], and dogs [5], CR has been
shown to increase longevity. Also, CR reduces the mor-
bidity of a host of diseases, including (but not limited
to), autoimmune diseases, atherosclerosis, cardiomyopa-
thies, cancer, diabetes, renal diseases, neurodegenerative
diseases, and respiratory diseases [6,7]. Multiple meta-
bolic pathways have been proposed to be involved in
the health-promoting effects of CR, as described in
detail previously [8-11]. In addition to an actual
reduction in kcal intake, selected nutrients (e.g., resvera-
trol) [12,13] and drugs (e.g., rapamycin) [14] proposed
to mimic the longevity producing effects of CR, are
actively being investigated as an alternative to restricting
dietary energy.
An alternative to CR, alternate-day fasting (ADF) con-
sists of two interchanging days; one day, subjects may
consume food ad libitum (sometimes equaling twice the
normal intake); on the other day, food is reduced or
withheld altogether [15]. Interestingly, while CR regi-
mens typically reduce body weight, ADF regimens often
allow for the maintenance of normal body weight,
because the subjects may gorge themselves during their
feeding days [16]. However, the life-extending benefits
of ADF may rival those of CR, particularly in regard to
reducing the respective risks of developing type 2 dia-
betes and cardiovascular disease [15].
While CR reduces caloric intake, CR combined with
exercise (CE) both reduces caloric intake (albeit to a
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caloric expenditure. Within the last decade, considerable
research has examined whether including exercise in a
CR regimen augments the benefits elicited by CR or
promotes additional benefits not observed in a CR-only
regimen. The results of these studies have been mixed.
Depending on the outcome measured, CE either aug-
ments a benefit elicited by CR alone [17-20], fails to do
so [21-24], or elicits a benef i tt h a tw a sn o te l i c i t e db y
CR alone [25].
Dietary restriction (DR) - restriction of one or more
components of intake (typically macronutrients) with
minimal to no reduction in total caloric intake - is
another alternative to CR. While research suggests that
neither carbohydrate restriction nor lipid restriction
extend life [26-32], protein restriction increases maxi-
mum lifespan by roughly 20% [30]. This extension of
life may be solely due to the reduction of the amino
acid methionine [33].
Many religions incorporate fasting for both spiritual
and physical benefits [34,35]. During the holy month of
Ramadan, which varies according to the lunar calendar,
Muslims abstain from eating or drinking from sunrise
(Sahur) to sunset (Iftar). Greek Orthodox Christians fast
for a total of 180 - 200 days annually including the fol-
lowing main fasting periods: the Nativity Fast (40 days
prior to Christmas), Lent (48 days prior to Easter), and
the Assumption (15 days in August). The Biblical-based
Daniel Fast typically incorporates a 21-day fasting period
in which individuals refrain from consuming animal
products, refined carbohydrates, food additives, preser-
vatives, sweeteners, flavorings, caffeine, and alcohol.
These above mentioned forms of fasting have been stu-
died using a laboratory-based approach, with findings
published in the scientific literature. Although limited
objective data are available for other forms of religiously
motivated fasts, including but not limited to practices
observed in China, Tibet, and India, as well as those of
B u d d h i s tm o n k s ,i ts h o u l db en o t e dt h a tf a s t i n gw i t h i n
these populations is commonplace. Hence, research
investigating the health-specific effects of fasting within
these samples is warranted.
The outline of this literature review is as follows: First,
data related to CR in both animals and humans will be
presented. Next, CE will be reviewed with regard to data
obtained from both animal and human investigations.
Data will then be presented in relation to ADF in both
animals and humans. DR, in particular protein restric-
tion and methionine restriction, will be considered as an
alternative to CR. Finally, the three aforementioned
forms of religious fasting will be presented. The paper
concludes by providing a summary and suggestions for
future research.
Caloric Restriction and Animals
Rodents and primates are the two most commonly stu-
died species in CR animal trials. Many studies use
rodents that have been altered genetically to develop
various morbidities, including cancer and diabetes.
Regarding primates, the majority of work is conducted
on rhesus monkeys [36-41].
Typically, caloric intake is reduced by 20 - 40% when
compared to ad libitum-fed control animals [2,42].
Despite having their caloric intake reduced, the animals
are provided sufficient amounts of nutrients and vita-
mins so as to avoid malnutrition [42]. The magnitude of
CR (i.e. the amount of calories that are reduced) is posi-
tively correlated with longevity until the point that CR
induces starvation [43].
Most studies initiate CR during the weaning phase and
continue throughout the animal’s lifespan. Short-term
CR has also been examined, with some studies lasting as
little as 10 days [44]. Similar to magnitude, the duration
of CR is positively correlated with longevity [43].
Several animal trials have found that CR improves car-
diovascular health [36,39,45-47]. Specifically, CR reduces
levels of triglyceride [36,39], phospholipid [36], and total
and low density lipoprotein (LDL) cholesterol [39]. CR
also increases HDL2b levels [39] and reduces inflamma-
tory markers [36,44,48] such as TNF-a, IL-6, C-reactive
protein, and NF-B. In addition to positive changes in
blood lipids, which appear to be associated with reduced
risk for cardiovascular disease, several studies have noted
significant declines in both blood pressure and heart rate
[36,39,45-47]. Moreover, other work has noted cardio-
protective alterations in gene expression [45,47].
In addition to cardiovascular-specific effects, CR causes
a variety of improvements related to overall health. CR
appears to improve glucoregulatory function and insulin
sensitivity, particularly in rodents and rhesus monkeys
[38,39,48-50]. Specifically, several studies have observed a
decrease in fasting blood glucose and insulin [38,39,49,50].
Regarding biomarkers of overall health, reductions in mar-
kers of oxidative stress such as hydrogen peroxide, protein
carbonyls, and nitrotyrosine have been noted [41,51-53].
Also, CR has been shown to lower brain-reactive antibo-
dies [54] and to reduce T-lymphocyte proliferation [55].
Moreover, CR has been reported to reduce tumor growth
[55,56], decrease body weight [39,55-57], reduce sarcope-
nia [58], maintain neural/cognitive function [57], and
improve immune function [54,55]. Collectively, these
changes have been associated with an increase in lifespan
in many studies involving animals [1,55,59,60].
Caloric Restriction and Humans
It is difficult to definitively answer whether or not CR
prolongs human life because of the ethical and logistical
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longevity directly, most human CR studies measure bio-
markers correlated with longevity. Collectively, these
studies have noted favorable changes in multifarious
biomarkers, particularly those related to cardiovascular
and glucoregulatory function.
As noted above, most animal CR studies initiate the
restriction of calories during the weaning phase and
continue throughout the subject’s lifespan. Obviously,
no human study has ever initiated CR that early or for
that long a duration. Instead, CR is typically instituted
for a period of 6 - 12 months [61-71]. However, a few
studies have examined CR for 2 years [72-74], ~6 years
[75-77], and longer [78].
The majority of work has been conducted on healthy,
middle aged, non-obese (normal or overweight) men
and women, with a significant amount of investigations
utilizing data obtained from the CALERIE (Comprehen-
sive Assessment of Long Term Effects of Reducing Calo-
ric Intake) program [61,64-67,69-71]. This program was
initiated by the National Institute on Aging to investi-
gate the adaptive responses of CR on free-living humans
[79]. In addition to the CALERIE program, another
investigation of importance, Biosphere 2, contained
eight subjects aged from 27-67 years [72-74]. These sub-
jects lived in an enclosed ~3 acre “ecological mini-
world” for two years [79]. Food intake was subnormal
due to the inability to grow enough food for ad libitum
consumption; hence, subjects followed a CR plan by
default. Aside from normal weight men and women,
investigations involving CR have also included obese
[80-83], diabetic [83], young [84,85], and elderly [78,86]
individuals.
Somewhat similar to the animal studies, daily caloric
intake has usually been reduced by 20-25% of the caloric
intake of ad libitum-fed control subjects [61-71,84].
Alternatively, some studies have reduced caloric intake
by a fixed number of calories rather than a percentage
of usual intake [82,83].
As mentioned above, numerous studies have found
that CR improves cardiovascular and glucoregulatory
health. Specifically, CR may reduce the risk of cardiovas-
cular disease by lowering total cholesterol, triglycerides,
blood pressure, and carotid intima-media thickness
[62,67,72,75,77]. CR also has been shown to attenuate
the age-related decline in diastolic function [77].
Regarding glucoregulatory health, circulating insulin
[64,70,73-75,86] and glucose [70,73-75] levels decrease -
while insulin sensitivity increases [70] - following a per-
iod of CR.
CR has also been shown to attenuate oxidative stress
[61,65,80-84,87], a condition thought to contribute to
aging and disease [88]. In addition, enhanced verbal
memory performance has been reported in elderly
individuals on a CR regimen as assessed by the Rey
Auditory Verbal Learning Task [86]. Unfortunately, CR
does not appear to retard the age-related loss of bone
[69] and muscle [71] mass.
Caloric Restriction combined with Exercise
Animals
A number of studies have examined whether the addi-
tion of exercise to a CR regimen (CE) augments any of
the health-promoting benefits caused by CR alone. Ani-
mal CE studies often feature a minimum of four groups:
1) a sedentary group fed ad libitum,2 )as e d e n t a r y
group fed a CR diet, 3) a voluntary exercise group fed
ad libitum, and 4) a voluntary exercise group fed a CR
diet. Male rats are often the animal of choice for CE
studies, because they do not increase their caloric intake
to compensate for their exercise-induced caloric expen-
diture [22]. Voluntary wheel running is typically the
exercise of choice for these studies.
Some studies have found that CE does not elicit
health-promoting benefits beyond those elicited by CR
[21-24]. The presence or absence of exercise does not
appear to affect oxidative stress levels or pro-inflamma-
tory protein levels in animals fed an 8% CR diet [21,24].
However, CE reduces C-reactive protein levels to a
greater extent than CR by itself [19]. Regarding myocar-
dial health, CE lowers the likelihood of developing both
myocardial necrosis and myocardial ischemia [17,18].
CE has been shown to attenuate age-related sarcopenia
to a greater extent than CR by itself [20]. Moreover, CE
reduces muscle fatigue and may increase the oxidative
capacity of muscle fibers [25]. However, the addition of
exercise to a CR regimen does not appear to affect an
animal’s maximal life span, the outcome of most interest
to most investigators [22]. Future work in this area
should focus on how different exercise intensities,
volumes, frequencies, and modalities affect the ability of
exercise to augment the health-promoting effects of CR.
Humans
Several CE studies have involved human subjects
[61,64,66,67,84,89-91]. Unlike the majority of the animal
CE studies, human CE studies typically quantify the
caloric expenditure caused by the exercise regimen.
Many human CE studies have incorporated a total calo-
ric reduction of 25%, with 12.5% coming from exercise-
induced expenditure and another 12.5% coming from
reduced caloric intake (i.e. diet) [61,64,66,67,89]. The
expenditure is often accomplished by performing aero-
bic exercise several (e.g. 5) days per week
[61,64,66,67,89].
Many investigations have noted no significant differ-
ence between CE and CR regarding their respective
effects on fasting insulin levels [64], DNA damage [61],
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levels [67], and liver lipid content [66]. In contrast to
these findings, two investigations have noted a further
reduction in both diastolic blood pressure and LDL cho-
lesterol with CE when compared to CR alone [67,89].
Moreover, other work has noted that CE improved insu-
lin sensitivity, while CR-alone failed to do so [89]. Also,
CE has been shown to increase bone mineral density at
the femoral neck and reduce sTNFR1, an inflammatory
biomarker, in overweight postmenopausal women [90].
Collectively, although results are somewhat mixed, it
appears that the addition of exercise to a CR plan may
provide further health benefits. Perhaps of main impor-
tance, it may be easier for an individual to comply with
a CE regimen than a CR regimen when total caloric
reduction (increased caloric expenditure combined with
decreased caloric intake) is held constant. For example,
a 12.5% reduction in dietary energy coupled with a
12.5% increase in expenditure due to exercise appears
much more manageable than a 25% reduction in dietary
energy (as is the case in many of the CR-only plans). In
an attempt to determine the optimal plan for improved
health, future work may investigate varying amounts of
exercise-induced caloric expenditure (i.e. less than or
greater than 12.5%) coupled with varying amounts of
decreased caloric intake. Indeed, compliance is of major
importance when considering long-term CR regimens.
Alternate-Day Fasting and Animals
ADF consists of alternating 24-hour periods of ad libi-
tum intake ("feast period”) and partial or complete
restriction of caloric consumption ("fast period”). Some
studies have withheld food altogether during the fast
period, while others have restricted caloric consumption
by as little as 25% of ad libitum intake [92]. Unlike CR,
ADF need not necessarily reduce overall caloric con-
sumption or bodyweight, because subjects may compen-
sate for the reduced caloric intake during fast periods by
gorging themselves during feast periods [15,16].
ADF has been found to extend lifespan in several ani-
mal trials [16,93,94]. Interestingly, Duan and colleagues
suggest that an increase in brain-derived neurotrophic
factor (BDNF) may mediate the observed life extension
c a u s e db ya nA D Fr e g i m e n[ 9 4 ] .T h ea b i l i t yo fA D Ft o
retard or prevent altogether the development of many
morbidities, including cardiovascular disease, kidney dis-
ease, cancers, and diabetes, may also explain some of
the observed increases in longevity [15,16,94-99].
Many animal ADF studies have noted improvements
in cardiovascular function. Both resting heart rate and
blood pressure are reduced following a period of ADF
[96,98,99]. Heart rate variability, which is associated
with improved cardiovascular function and a reduced
probability of heart failure, has been noted to be
favorably affected by ADF in rats [100]. Ahmet and col-
leagues [95] noted a prophylactic ability of ADF to
attenuate the development of post-infarct chronic heart
failure. In this work, the investigators induced myocar-
dial infarction (MI) in Sprague-Dawley rats that had
been following a diet of either ADF or ad libitum
i n t a k e .W h e nc o m p a r e dt ot h ead libitum-fed group,
the rats on the ADF schedule had less left ventricle
remodeling and functional decline following the MI.
Glucoregulatory function is also typically improved
following an ADF regimen. ADF can improve insulin
sensitivity, which results in lower fasting glucose and
insulin concentrations and improved glucose tolerance
[16,99]. However, Mager et al. [96] noted that glucose
concentrations did not change in Sprague-Dawley rats
following a period of ADF, although glucose concentra-
tions were reduced following a 40% CR plan during the
same time period. In contrast, Anson et al. [16] noted
that glucose and insulin concentrations were reduced by
a similar extent (compared to a control group) in both
an ADF group and a 40% CR group.
One of the most germane questions regarding ADF is
whether or not it can elicit benefits that are comparable
to CR, a question best answered by including both plans
w i t h i nt h es a m er e s e a r c hd e s i g n .W h i l es o m es t u d i e s
have done just that, as indicated by the work of Anson
et al. [16] and Mager et al. [96] presented above, most
have not. This highlights one of the main directions that
should be taken in future research regarding CR and
ADF.
Alternate-Day Fasting and Humans
Of the ADF trials that have been performed, relatively
few have used human subjects. Originally, human trials
were performed simply to examine the feasibility of
maintaining an ADF regimen [101]. Now that feasibility
has been established, research turns to examining what
health-related benefits ADF can yield and through
which mechanisms these benefits are yielded.
In human ADF trials, subjects have been permitted to
c o n s u m ea n y w h e r ef r o m0 %t o5 0 %o ft h ee s t i m a t e d
daily energy required to maintain body mass during fast
periods [102]. Few human ADF studies incorporate a
fasting period lasting longer than 20 weeks due to ethi-
cal and logistical (i.e. compliance) limitations. In fact,
many trials have lasted only a few days. Most subjects
are able to remain compliant throughout their fast, and
few experience any fast-related health complications.
However, as expected, subjects often report hunger and
irritability during fast days (as measured via question-
naires), which calls into question the sustainability of
long-term ADF diets [101]. Despite being able to con-
sume food ad libitum during feast days, human subjects
sometimes experience weight loss as a result of the ADF
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weight by gorging themselves during feast periods
[15,16]. Interestingly, Heilbronn and colleagues [101]
examined nonobese humans and noted that subjects
that classified themselves as “big eaters” lost less weight
than those that claimed that they “watched what they
ate.” This suggests the possibility that obese subjects
might gorge themselves during feast days and conse-
quently not lose weight on an ADF regimen.
Human trials have noted mixed findings with ADF
regarding glucoregulatory function. Heilbronn and col-
leagues [101] noted a decrease in fasting insulin but no
difference in fasting glucose following 22 days of ADF.
Another study by the same group [103] found that
women on a 22 day ADF regimen cleared serum glucose
following a test meal (500 kcal, 12.2 g fat, 90 g carbohy-
drate, 17.6 protein) less efficiently when compared to
pre-fast values; no difference in glucose clearance effi-
ciency was seen in men. In the same study, men on an
ADF diet experienced a reduced insulin response to the
test meal, but this effect was not observed in women.
Taken together, these findings suggest that men and
women may respond differently to ADF. In addition,
H a l b e r ge ta l .[ 1 0 4 ]f o u n dn ochange in fasting glucose
or insulin concentrations in men (this study did not
include women) following a 14-day ADF program.
Future studies should examine potential causes for the
sex-specific differences noted above.
Johnson and colleagues [105] noted substantial bene-
fits from an 8-week long ADF regimen on overweight,
asthmatic subjects. Nine subjects consumed food ad
libitum on feast days and one meal replacement shake,
which consisted of either 320 or 380 kcals for women
and men, respectively, on fast days. Peak Expiratory
Flow (PEF) significantly increased within 2 weeks of the
ADF diet; however, forced expiratory volume (FEV1) did
not increase following the protocol. The beneficial
effects of albuterol administration were greater following
the 8 weeks of ADF compared to baseline values. The
authors suggest that the diet improved “bronchial
responsiveness.” Scores on questionnaires such as the
Juniper mini-Asthma Quality of Life Questionnaire
(mini-AQLQ) and Asthma Symptom Utility Index
(ASUI) indicated that subjects’ q u a l i t yo fl i f ew a s
improved following the ADF regimen.
Johnson and colleagues have examined ADF regimens
over the course of several years, including over 500 sub-
jects as of 2006. The authors have noted improvements
in the following: insulin sensitivity, asthma, seasonal
allergies, autoimmune diseases such as rheumatoid
arthritis, osteoarthritis, infectious disease of viral, bacter-
ial, and fungal origin, inflammatory central nervous sys-
tem lesions involved with Tourette’ss y n d r o m ea n d
Meniere’s disease, cardiac arrhythmias, and menopause-
related hot flashes [102]. Much remains to be known
regarding the mechanisms responsible for the effects of
ADF on these outcomes. Moreover, data pertaining to
the use of ADF in human subjects are not yet available
in regard to biomarkers specific to blood lipids, oxida-
tive stress, and inflammation. Clearly, this area of
research has the potential for new discovery.
Dietary Restriction
Whereas CR is a reduction of caloric intake, DR is a
specific reduction/manipulation in nutrient intake. DR
need not necessarily result in CR, because the reduced
intake of a particular nutrient (typically a macronutri-
ent) may be offset by an increased intake of one or
more other nutrients. For example, if carbohydrate
intake is reduced, then protein and/or lipid intake can
be increased so as to maintain normal caloric intake.
Given this, DR appears to be considerably more toler-
able than CR, especially when considering that some
researchers estimate that energy consumption must be
reduced by a minimum of 20 - 25% in order to beget
any life-extending benefits from a CR regimen
[59,106,107]. Consequently, many studies have
attempted to determine if DR can elicit life-extending
effects comparable to CR. This area of study may be
partly motivated by the work of Simpson and coworkers
[108] who have proposed that state-space geometric
models can be used to determine the influence of kcal
reduction and specific nutrients on longevity and asso-
ciated outcome measures.
Neither carbohydrate restriction nor lipid restriction
appear to be effective alternatives to CR. Lipid restric-
tion has been shown to have no effect on longevity
[26,27]. Regarding carbohydrate, several studies have
found that increasing intake either increases or has no
effect on longevity, suggesting that restriction would not
extend life [28,29], also reviewed in [30]. Moreover,
both forms of macronutrient restriction fail to decrease
reactive oxygen species production or oxidative DNA
damage [31,32].
Protein restriction appears to be a viable candidate for
an alternative to CR. Sixteen out of 18 reviewed experi-
ments found that protein restriction increased maxi-
mum lifespan in rodents (reviewed in [30]). The average
increase in maximum lifespan in the 16 positive studies
was approximately 20%. When this is compared to the
~40% increase in lifespan found in many CR investiga-
tions, it suggests that protein restriction accounts for
approximately half of this effect [30]. Moreover, several
of the reviewed studies compensated for the reduction
in protein by increasing carbohydrate intake; this
balanced total caloric intake and ensured that the pro-
longation of life was due to restriction of protein and
not calories.
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whether restriction of an individual amino acid accounts
for most or all of the life-extending benefits of protein
restriction. While a few studies have found that trypto-
phan restriction increases lifespan [109,110], the major-
ity of studies have focused on methionine restriction. As
with tryptophan restriction, methionine restriction
increases longevity [111-115]. Forty percent methionine
restriction has been reported to decrease both mito-
chondrial reactive oxygen species generation and oxida-
tive damage in mitochondrial DNA [116,117]. Further
evidence that methionine restriction increases longevity
(reviewed in [118]): 1) methionine content has an
inverse relationship with maximum life span in mam-
mals [119]; 2) of the amino acids, methionine is one of
the most vulnerable to oxidation by reactive oxygen spe-
cies [120]; 3) methionine supplementation increases
LDL cholesterol oxidation [121]; and 4) raising methio-
nine intake increases plasma homocysteine concentra-
tions, which in turn elevates the risk of cardiovascular
disease and mortality [121].
In an effort to disentangle the respective effects of
methionine restriction and protein restriction, Caro and
coworkers [33] examined the impact of 40% restriction
of all dietary amino acids except methionine on biomar-
kers of aging. The investigators found that this restric-
tion failed to reduce both mitochondrial reactive oxygen
species generation and oxidative damage in mitochon-
drial DNA. The authors concluded that methionine is
the only amino acid that can affect mitochondrial reac-
tive oxygen species generation and subsequent oxidative
stress by manipulating its intake.
In summary, neither carbohydrate restriction nor lipid
restriction appear to be responsible for the life extension
caused by CR, while approximately half of the life exten-
sion effect of CR seems to be ascribable to protein
restriction. A wealth of evidence indicates that methio-
nine restriction might account for most or all of the
life-extending benefits of protein restriction. Fortunately,
a methionine-restricted diet is both feasible and toler-
able [122], suggesting that it might be an attractive
alternative to CR for those seeking the health-enhancing
properties of such a plan. However, because the evi-
dence provided above has been generated using animal
models, further work involving human test subjects is
necessary before firm conclusions can be made.
Religious Fasting
Several religions place one or more of the following
restrictions on food consumption: 1) the types of foods
permitted for consumption in general or during particu-
lar times of the year; 2) the time of day when food con-
sumption is permitted; and 3) food preparation [34].
These types of restrictions can either persist year-round
or be active only during special fasting periods. The text
below focuses on the following fasting periods: 1) Isla-
mic Ramadan; 2) the three principal fasting periods of
Greek Orthodox Christianity (Nativity, Lent, and the
Assumption); and 3) the Biblical-based Daniel Fast. The
reason for the inclusion of these religious fasts in this
review and the exclusion of others is that, to our collec-
t i v ek n o w l e d g e ,t h e s ea r et h eo n l yf a s t sa b o u tw h i c h
scholarly research has been performed that explicitly
detailed the subjects’ dietary intake.
Ramadan
During the holy month of Ramadan, all healthy adult
Muslims are forbidden from consuming any food or
water from sunrise (Sahur) to sunset (Iftar). Food and
fluid intake become nocturnal during Ramadan, and the
common practice is to eat one large meal after sunset
and one lighter meal before dawn [123]. Ramadan is
clearly the most commonly researched religious fast.
The collective work highlights both the positive and
negative effects of Ramadan fasting on overall health.
It was previously thought that Ramadan fasting often
led to reduced energy intake and weight loss [124], but
r e c e n ts t u d i e sh a v ef o u n dt h a tc a l o r i ci n t a k ea c t u a l l y
increases despite the decreased meal frequency [125]. In
relation to macronutrient composition, meals are often
composed of more fat and less carbohydrate during
Ramadan than during the rest of the year [126,127].
Ramadan fasting has elicited mixed results in relation
to cardiovascular health, particularly regarding lipid pro-
files. Hallak and Nomani [124] and Ziaee et al. [128]
noted a decline in high density lipoprotein (HDL)-C
levels and an increase in LDL-C levels following Rama-
dan fasting. However, several other studies have found
an increase in HDL-C levels and a decline or no change
in LDL-C levels [125,127,129-131]. Indeed, some studies
have noted an increase in HDL-C levels by as much as
20% [125] and 30% [131]. The majority of studies have
found no difference in triglyceride levels [130-132],
w h i l eo n es t u d yn o t e dad e c r e a s ef o l l o w i n gap e r i o do f
Ramadan fasting [123]. Salehi and Neghab [132]
reported declining total cholesterol levels following a
Ramadan fast. Conversely, Aksungar et al [130] did not
note any changes in total cholesterol and LDL-C levels
but did note decreases in the TC/HDL ratio, C-reactive
protein levels, and homocysteine levels.
Changes in heart rate and blood pressure have also
been observed during Ramadan. Husain et al [133]
observed a significant lowering of resting heart rate in
men, although no changes were noted regarding the
resting heart rate of women. Heart rate during steady-
state aerobic exercise has also been shown to decrease
during the fast compared to non-fasting values
[134,135]. Regarding blood pressure, one study noted a
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pressure -although this change was noted in both fasters
and non-fasters, raising a question regarding the ability
of Ramadan fasting to actually promote such an effect
[136] while four studies found no difference in either
variable [135,137-139]. Ramadan (2002) [135] compared
blood pressure changes during steady-state aerobic exer-
cise during and after Ramadan fasting. Systolic - but not
diastolic - blood pressure significantly increased during
exercise when subjects were fasting. Contrastingly,
neither systolic nor diastolic blood pressure changed
during exercise in subjects who were not fasting.
To our knowledge, only two studies to date have
examined the effects of Ramadan fasting on oxidative
stress and antioxidant status, highlighting an important
a r e af o rf u t u r er e s e a r c h .I b r a h i me ta l[ 1 2 3 ]o b s e r v e da
reduction in malondialdehyde (MDA) erythrocyte con-
centrations, while no changes were noted regarding
levels of either serum MDA or plasma protein-bound
carbonyls. No changes were found regarding the con-
centration of glutathione or the activities of glutathione
peroxidase and catalase in erythrocytes. Plasma levels of
ß-cryptoxanthin and total carotenoids significantly
decreased during Ramadan fasting, and plasma levels of
vitamin C, b-carotene, lycopene, and lutein were non-
significantly reduced. No changes were noted regarding
plasma levels of a-tocopherol, g-tocopherol, retinol, a-
carotene, and zeaxanthin. Chaouachi and colleagues
[140] reported that blood levels of vitamin A increased,
while blood levels of vitamin E decreased during Rama-
dan fasting.
As with the reports of Ramadan’s effects on markers
of cardiovascular health, similarly mixed results are
available regarding Ramadan fasting and the ability to
improve glucoregulatory health. Two studies have noted
a decrease in fasting blood glucose following Ramadan
[123,132], while a recent study noted no effect on blood
glucose levels [131]. Kassab et al [141] noted that serum
leptin levels increased during Ramadan by 37% and 39%
in obese and nonobese subjects, respectively. Addition-
ally, the authors found a significant correlation between
changes in serum leptin and serum insulin levels, which
suggests that insulin may play a role in regulating leptin
secretion [141].
Aside from the potentially beneficial effects discussed
above, some studies have noted adverse effects asso-
ciated with Ramadan fasting. Ramadan fasting has been
shown to negatively impact nocturnal sleep by increas-
ing sleep latency and decreasing both slow wave sleep
and rapid eye movement sleep [142,143]. Lack of sleep
can cause irritability [144] and has been shown to lead
to an increase in the intake of stimulants such as coffee
and tea during the month of Ramadan [145]. Ramadan
fasting may lead to ulcer complications, as studies have
reported increased gastric acidity during the day, with
altered circadian patterns of levels of plasma gastrin,
gastric pH, glucose and calcium [146]. Other potential
adverse health effects associated with Ramadan fasting
include energy level imbalances [124], dehydration
[147], decreased athletic performance [148], and altered
circadian fluctuations in hormone levels [149].
Collectively, the above-listed studies have reported
conflicting effects of Ramadan fasting on a number of
health-related biomarkers. There are several potential
confounding variables that may influence the effect of
Ramadan fasting on these biomarkers, including: age,
physical activity, diet, sleep cycles, and cultural habits
[126,150]. Regarding the latter, El-Ati et al. [126]
reported that total energy intake increased among Saudi
subjects and decreased among Indian subjects during
Ramadan, and that this discrepancy was due to the dif-
ferences in food choices between the two groups. Food
choices and eating habits affect metabolism and could
potentially affect the above-listed biomarkers. Future
investigations should take these variables - as well as
other confounding variables - into consideration.
Greek Orthodox
There are three principal fasting periods for Greek
Orthodox Christians. During the 40 days that precede
Christmas (Nativity), dairy products, eggs, and meat are
proscribed every day, while fish and olive oil are also
forbidden on Wednesdays and Fridays. During the 48
days that precede Easter (Lent), dairy products, eggs,
and meat are proscribed. Olive oil consumption is per-
mitted only on weekends during this period, and fish
consumption is only allowed on March 25
th and Palm
Sunday. During the first 15 days of August (the
Assumption), dairy products, eggs, and meat are pro-
scribed. Olive oil consumption is permitted only on
weekends during this period, and fish consumption is
only allowed on August 6
th. Cheese, eggs, fish, meat,
milk, and olive oil are also proscribed on every Wednes-
day and Friday that falls outside of the principal fasting
periods. This latter proscription is temporarily lifted on
the week following Christmas, Easter, and the Pentecost.
Collectively, dietary consumption is restricted for 180-
200 days each year.
Most studies have reported a decreased caloric intake
during the fasting periods [151-154], which may result
in lowered body mass [151,152]. Percentagewise, carbo-
hydrate intake appears to increase, while both protein
and fat intake decrease [151-153]. Both saturated fat and
trans-fatty acid consumption appear to decrease during
fasting periods, while both monounsaturated and poly-
unsaturated fat consumption do not change [151,153].
Both total cholesterol and LDL-C levels decrease dur-
ing fasting periods [151,152], while conflicting results
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that the LDL/HDL ratio does not change during Greek
Orthodox Christian fasting [152], while conflicting
results have been noted regarding both the total/HDL
ratio and triglyceride levels [151,152]. Greek Orthodox
Christian fasting appears to have no effect on blood glu-
cose levels [151,152], although fiber intake increases
during fasting periods [151-155].
Both riboflavin [151] and calcium [151,153,155] intake
appear to decrease during fasting periods, while magne-
sium intake appears to increase [151,155]. The intake of
the following vitamins and minerals do not appear to
change during fasting periods: vitamin A [151,153]; thia-
min [151]; niacin [153]; vitamin B12 [151,153]; vitamin C
[151,153,154]; vitamin E [151,153]; phosphorus [151];
potassium [151,155]; and zinc [151]. Mixed results have
been recorded regarding the intake of both folate
[151,153,155] and sodium [151,155].
To our knowledge, only one study has examined the
effects of Greek Orthodox Christian fasting on other
hematological variables [154]. The authors reported that
fasters experienced a relative increase in serum ferritin
levels, a relative decrease in MCHC levels, and no rela-
tive change in levels of hemoglobin, serum iron, and
transferrin when compared with non-fasters during the
Christmas fasting period. The authors also reported that
the non-fasters’ hematocrit declined significantly (42.7 ±
5.1 vs. 41.2 ± 5.1%) when compared to the changes in
fasters’ hematocrit (41.2 ± 3.9 vs. 40.0 ± 5.3%). However,
this change is of little to no clinical relevance, as all
values were within normal range.
There are conflicting findings on the effects of Greek
Orthodox Christian fasting on blood pressure. One
study found that systolic blood pressure increased dur-
ing fasting periods [151], while another study found no
change in systolic blood pressure when fasters were
compared with non-fasters [155]. One study reported
that non-fasters’ diastolic blood pressure decreased sig-
nificantly during fasting periods when compared to the
changes in fasters’ diastolic blood pressure [155], while
another study reported that fasters’ diastolic blood pres-
sure did not change during fasting periods [151].
In summary, Greek Orthodox Christian fasting
appears to lower caloric intake and body mass, and both
total and LDL-C decrease during fasting periods. The
intake of most vitamins and minerals do not appear to
change during these periods, although riboflavin and
calcium intake each appear to decrease, and magnesium
intake appears to increase. More research remains to be
performed on hematological variables and blood pres-
sure during fasting periods due to both the lack of pre-
vious research and the inconclusive findings. Also,
future studies should examine each of the three princi-
pal fasting periods both separately and aggregately,
because each fasting period has unique food proscrip-
tions and durations.
Daniel Fast
A popular fast practiced by many Christians and Jews is
the Daniel Fast, based on the Biblical story of Daniel
(1:8-14), in which Daniel resolved not to defile himself
with the royal food and wine, and he asked the chief
official for permission to provide to him and his three
friends nothing but vegetables to eat and water to drink
for 10 days. Later in the same book (Daniel 10:2-3),
Daniel again partook in a 21 day period of “clean” eat-
ing, during which time he ate no choice food (meat or
wine). Based on these two stories, a modern day Daniel
Fast involves ad libitum intake of certain foods, but the
food choices are restricted to essentially fruits, vegeta-
bles, whole grains, nuts, seeds, and oil. In essence, this
plan is a form of DR and resembles a vegan diet, which
has been reported to yield health-enhancing properties
[156,157]. However, a Daniel Fast is much more strin-
gent, because preservatives, additives, sweeteners, flavor-
ings, caffeine, and alcohol are each forbidden. However,
because individuals traditionally follow this fast for reli-
gious purposes in an attempt to become “closer to God”
during a time of extended prayer, the anecdotal reports
have indicated excellent compliance.
To test the health benefits of the Daniel Fast within a
laboratory-based protocol, we recently enrolled 43 sub-
jects (13 men; 30 women; 35 ± 1 yrs; range: 20-62 yrs)
to complete a 21-day Daniel Fast. Pre and post interven-
tion, subjects underwent a variety of tests including
measures of body weight and composition (measured
via dual energy x-ray absorptiometry), resting blood
pressure and heart rate, fasting blood measures of oxida-
tive stress, inflammation, blood lipids, insulin, and glu-
cose. Subjects’ self reported compliance, mood, and
satiety in relation to the fast were also recorded.
We noted excellent compliance to the fast (98.7 ±
0.2%; mean ± SEM), as well as excellent mood and sati-
ety (7.9 ± 0.2 using a 10 point scale). The following vari-
ables related to cardiovascular disease risk were
significantly (p < 0.05) lower following the fast as com-
pared to before the fast: total cholesterol, LDL-C, SBP,
and DBP. Insulin, HOMA-IR, and C-reactive protein,
although lowered to a clinically meaningful extent, were
not of statistical significance. Unfortunately, due to the
drastic decrease in total cholesterol, HDL-C was lower
after the fast as compared to before the fast (55.65 ±
2.50 vs. 47.58 ± 2.19 mg·dL
-1). Although body weight
and body fat were reduced slightly, no significant differ-
ence was noted [158]. In reference to measures of oxida-
tive stress, we noted a significant increase (p < 0.05) in
Trolox Equivalent Antioxidant Capacity, and a signifi-
cant decrease (p < 0.05) in malondialdehyde and
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above have been noted in a recent follow-up investiga-
tion of the Daniel Fast (unpublished findings).
The above data demonstrate that a Daniel Fast can
significantly improve several biomarkers of overall
health, particularly those related to cardiovascular and
metabolic disease. Larger scale, randomized studies will
be needed to extend these preliminary findings. Future
studies should consider extending the duration of the
fast, as well as modifying food choices in an effort to
maintain HDL-C levels.
Overall Summary and Conclusions
CR has been demonstrated to extend the maximal life-
span of a diverse group of species. This extension of life
is maximized when: 1) the magnitude of CR is elevated
to the highest possible value before inducing malnutri-
tion and 2) the duration of CR is maximized. Animals
on CR regimens exhibit a variety of improvements in
overall health in general and cardiovascular health in
particular. Unfortunately, the likelihood of discovering
whether or not CR extends human life is rather remote
due to the ethical and logistical limitations of research
design. The optimal magnitude and duration of CR for
humans will also likely never be known for the same
reason. Nonetheless, many human CR studies have
noted favorable changes in biomarkers related to cardio-
vascular and glucoregulatory function, which likely
relate to quality of life and may relate to longevity.
Due to the austerity of following a CR regimen of suf-
ficient magnitude and duration, alternatives such as CE,
A D F ,a n dD Rm a yp r o v et ob em o r ea p p e a l i n g .T h e
most pertinent consideration to make when evaluating
these alternatives is whether or not they elicit benefits
that are comparable to CR. ADF has been demonstrated
to extend life and improve both cardiovascular and glu-
coregulatory function in animals. Human trials have
noted heterogeneous findings and sex-specific differ-
ences regarding ADF’s effects on glucoregulatory func-
tion. Unfortunately, it is difficult to compare the effects
of ADF and CR regimens across different studies due to
an enormous number of confounding variables. Future
studies should feature an ADF group and a CR group so
that direct comparisons can be made. Regarding DR,
neither carbohydrate restriction nor lipid restriction
extend life. However, protein restriction appears to
extend maximum lifespan by 20%. Recent findings sug-
gest that methionine restriction may be the single cause
of life extension observed in protein restriction studies.
Future studies should examine the effects of different
magnitudes of methionine restriction on life extension.
As noted above, considerable research has recently
focused on whether CE augments any of the health-
promoting benefits caused by CR alone. Very few con-
clusions can currently be made due to the mixed results
of the studies. CE does not appear to extend life beyond
any extension observed to be caused by CR. However,
CE may be more manageable for many individuals due
to the smaller reduction in dietary calorie consumption.
Future work in this area should examine different exer-
cise intensities, volumes, frequencies, and modalities.
Also, future work should compare different amounts of
exercise-induced caloric expenditure.
Islamic Ramadan, the three principal fasting periods of
Greek Orthodox Christianity, and the Daniel Fast each
provide a unique and interesting vantage point for eval-
uating the effects of food restriction/modification. The
majority of findings related to Ramadan fasting are
mixed, and these discrepancies are most likely due to
the differences in cultural norms - particularly dietary
norms - of the groups studied. The three Greek Ortho-
dox Christian fasts appear to decrease body mass and
lower both total and LDL cholesterol levels, although
these fasts minimally affect t h ei n t a k eo fm o s tv i t a m i n s
and minerals. Finally, the Daniel Fast is associated with
profound and favorable effects on a variety of markers
related to human health, including blood pressure,
blood lipids, insulin sensitivity, and biomarkers of oxida-
tive stress.
This paper has touched on some of the numerous
methods of restricting dietary intake. Whether one
chooses to restrict energy intake daily, fast every other
day, restrict intake of a particular macronutrient, or fast
for religious purposes, the authors hope that this paper
can serve as a valuable tool to understanding the ability
of dietary modification to improve overall health and
the quality of life. Furthermore, we hope that this infor-
mation will fuel the development of new ideas and
research studies focused on investigating the health ben-
efits of caloric and dietary restriction.
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